30 19

Cited 1 times in

Bioresorbable Vascular Scaffold Korean Expert Panel Report

Authors
 Jung-Min Ahn  ;  Duk-Woo Park  ;  Sung Jin Hong  ;  Young Keun Ahn  ;  Joo-Yong Hahn  ;  Won-Jang Kim  ;  Soon Jun Hong  ;  Chang-Wook Nam  ;  Do-Yoon Kang  ;  Seung-Yul Lee  ;  Woo Jung Chun  ;  Jung Ho Heo  ;  Deok-Kyu Cho  ;  Jin Won Kim  ;  Sung-Ho Her  ;  Sang Wook Kim  ;  Sang-Yong Yoo  ;  Myeong-Ki Hong  ;  Seung-Jea Tahk  ;  Kee-Sik Kim  ;  Moo Hyun Kim  ;  Yangsoo Jang  ;  Seung-Jung Park 
Citation
 Korean Circulation Journal, Vol.47(6) : 795-810, 2017 
Journal Title
 Korean Circulation Journal 
ISSN
 1738-5520 
Issue Date
2017
Keywords
Bioresorbable vascular scaffold ; Coronary disease ; Stents ; Thrombosis
Abstract
Bioresorbable vascular scaffold (BRS) is an innovative device that provides structural support and drug release to prevent early recoil or restenosis, and then degrades into nontoxic compounds to avoid late complications related with metallic drug-eluting stents (DESs). BRS has several putative advantages. However, recent randomized trials and registry studies raised clinical concerns about the safety and efficacy of first generation BRS. In addition, the general guidance for the optimal practice with BRS has not been suggested due to limited long-term clinical data in Korea. To address the safety and efficacy of BRS, we reviewed the clinical evidence of BRS implantation, and suggested the appropriate criteria for patient and lesion selection, scaffold implantation technique, and management.
Files in This Item:
T999900242.pdf Download
DOI
10.4070/kcj.2017.0300
Appears in Collections:
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실)
Yonsei Authors
홍명기(Hong, Myeong Ki) ORCID logo https://orcid.org/0000-0002-2090-2031
Export
RIS (EndNote)
XLS (Excel)
XML
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/165772
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse